Downing’s Co-head of Healthcare Ventures, John E. Milad, recently spoke to Stephen Hansen, who is the Director of Biopharma Intelligence, about the recent Mansion House reforms.

Under the Mansion House Compact, the voluntary agreement unveiled last week between the government and nine of the largest U.K. defined contribution pension funds, the funds agreed to allocate at least 5% of investments specifically in unlisted equities by 2030.

John discusses the direction of pension fund capital against the backdrop of these crucial reforms.

Read the full article (please note the original article is behind a paywall)